Evolution of autoreactive GC and epitope spreading in lupus

狼疮自身反应性GC和表位扩散的演变

基本信息

  • 批准号:
    10399632
  • 负责人:
  • 金额:
    $ 46.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-13 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

EVOLUTION OF AUTOREACTIVE GC AND EPITOPE SPREADING IN LUPUS Systemic lupus erythematosus (SLE) is an incurable autoimmune disease and represents a substantial health problem in the population. Longitudinal studies of patients and murine models of SLE identify development of autoantibodies against new epitopes over time that correlate with increased pathology. The phenomena is referred to as epitope spreading, i.e. development of autoantibodies against determinants other than the initiating self-antigen. While the mechanism underlying epitope spreading remains unclear, we propose that spontaneous autoreactive GC initiated by a single B cell clone along with T cell help can promote entry of multiple distinct clones of naïve self-reactive B cells where they can be positively selected and undergo affinity maturation, compete and differentiate into effector cells leading to epitope spreading. In order to characterize the dynamics of spontaneous autoreactive GC in more depth, we developed a novel mixed bone marrow chimeric model in which bone marrow from a lupus strain is mixed with marrow from WT mice and transferred into irradiated recipients. In characterization of the chimeras, we found, unexpectedly, that the self-reactive WT B cells underwent clonal selection and affinity maturation resulting in one or two clones dominating the GC response much like that observed for foreign antigen. Furthermore, we identified epitope spreading by the WT B cells (Degn 2017). Thus, in contrast to the predicted negative selection of self- reactive clones in GC, we found robust positive selection with the generation of pathogenic antibodies specific for self-antigens distinct from the original nucleolar antigen. In the current proposal, we will characterize further the events initiating spontaneous autoreactive GC using both radiation chimeras and a parabiosis approach. Further, we will determine the role of T follicular helper cells in promoting epitope spreading. Three aims are proposed: Aim 1. Characterize the dynamics of autoreactive germinal centers leading to epitope spreading. Aim 2. Characterize Tfh in epitope spreading of self-reactive GC B cells. Aim 3. Test hypothesis that self-reactive memory B cells cycle through GCs and diversify.
狼疮患者自身反应性gc的进化与表位扩散

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Craig Carroll其他文献

Michael Craig Carroll的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Craig Carroll', 18)}}的其他基金

Astrocyte-neuron communication and vulnerability to mental illness
星形胶质细胞-神经元通讯和患精神疾病的脆弱性
  • 批准号:
    10686440
  • 财政年份:
    2022
  • 资助金额:
    $ 46.17万
  • 项目类别:
Neuroimmune mechanisms of adolescent brain development and vulnerability
青少年大脑发育和脆弱性的神经免疫机制
  • 批准号:
    10686442
  • 财政年份:
    2022
  • 资助金额:
    $ 46.17万
  • 项目类别:
Contributions of human C4A overexpression to schizophrenia pathogenesis.
人类 C4A 过度表达对精神分裂症发病机制的贡献。
  • 批准号:
    10686441
  • 财政年份:
    2022
  • 资助金额:
    $ 46.17万
  • 项目类别:
Administrative Core (Core A)
行政核心(核心A)
  • 批准号:
    10686439
  • 财政年份:
    2022
  • 资助金额:
    $ 46.17万
  • 项目类别:
Evolution of autoreactive GC and epitope spreading in lupus
狼疮自身反应性GC和表位扩散的演变
  • 批准号:
    10736511
  • 财政年份:
    2018
  • 资助金额:
    $ 46.17万
  • 项目类别:
Type I interferon-dependent mechanisms of synapse loss in lupus
狼疮突触丢失的 I 型干扰素依赖性机制
  • 批准号:
    10433932
  • 财政年份:
    2018
  • 资助金额:
    $ 46.17万
  • 项目类别:
Type I interferon-dependent mechanisms of synapse loss in lupus
狼疮突触丢失的 I 型干扰素依赖性机制
  • 批准号:
    10196940
  • 财政年份:
    2018
  • 资助金额:
    $ 46.17万
  • 项目类别:
Project-004
项目-004
  • 批准号:
    10686445
  • 财政年份:
    2017
  • 资助金额:
    $ 46.17万
  • 项目类别:
Neural-immune mechanisms and synaptic connectivity in psychiatric illness
精神疾病中的神经免疫机制和突触连接
  • 批准号:
    9280281
  • 财政年份:
    2017
  • 资助金额:
    $ 46.17万
  • 项目类别:
Astrocyte-neuron communication and vulnerability to mental illness
星形胶质细胞-神经元通讯和患精神疾病的脆弱性
  • 批准号:
    10693115
  • 财政年份:
    2017
  • 资助金额:
    $ 46.17万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 46.17万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 46.17万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 46.17万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 46.17万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 46.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 46.17万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 46.17万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 46.17万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 46.17万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 46.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了